The global In - Vitro ADME Services market size was valued at USD 819.5 million in 2022 and is forecast to a readjusted size of USD 1452.2 million by 2029 with a CAGR of 8.5% during review period.
In the early stages of drug discovery, it is important to understand the key physicochemical properties and structural motifs that drive the efficacy and safety profile of a compound candidate. In vitro ADME is used to identify the attributes of absorption, distribution, metabolism, and excretion. ADME assays are critical in gaining insight into metabolism and potential drug interactions.
Global In - Vitro ADME Services companies include Charles River, Labcorp, Envigo, Curia, Evotec, etc. Global top 3 companies hold a share over 32%. North America is the largest market, with a share about 47%, followed by Europe and Asia-Pacific.
This report is a detailed and comprehensive analysis for global In - Vitro ADME Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global In - Vitro ADME Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global In - Vitro ADME Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global In - Vitro ADME Services market size and forecasts, by Type and by End User, in consumption value ($ Million), 2018-2029
Global In - Vitro ADME Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In - Vitro ADME Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In - Vitro ADME Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Small Molecules
Biologics
Biopharmaceutical Companies
Government and Academic Institutes
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Strengths:
- Increasing demand for drug discovery and development services due to the need for cost-effective and efficient testing.
- Advancements in technology, such as high-throughput screening and automated testing, enhancing service capabilities and precision.
Weaknesses:
- Limited adoption in small pharmaceutical companies due to high initial costs of setting up in-vitro testing infrastructure.
- Dependency on regulatory approvals and lengthy validation processes that may delay market penetration.
Opportunities:
- Growth in the biotechnology and pharmaceutical industries driving higher demand for ADME (Absorption, Distribution, Metabolism, and Excretion) testing services.
- Rising focus on personalized medicine and targeted drug therapies leading to an increased need for in-vitro testing services.
Threats:
- Emergence of alternative testing methods, such as in-silico models, which may reduce the demand for traditional in-vitro services.
- Increasing competition from both established players and new entrants offering lower-cost services.
Political:
- Regulatory frameworks in different regions may impact market entry and the adoption of in-vitro ADME testing services.
- Government initiatives to promote drug safety and efficacy testing could drive market growth.
Economic:
- Rising healthcare expenditures and the growing pharmaceutical industry are likely to increase demand for ADME testing services.
- Budget constraints in small pharmaceutical companies may limit their ability to adopt in-vitro testing services.
Social:
- Growing awareness of drug safety and personalized medicine may increase demand for accurate in-vitro testing.
- A shift toward preventive healthcare and precision medicine could drive further growth in ADME testing services.
Technological:
- Advancements in automation, AI, and machine learning enhance the efficiency and precision of in-vitro ADME testing.
- Ongoing improvements in testing models and technologies could lead to faster and more accurate results, expanding service offerings.
Environmental:
- Environmental concerns regarding chemical waste from traditional testing methods may encourage the adoption of greener in-vitro testing alternatives.
- Increased focus on sustainability in the pharmaceutical industry could impact demand for environmentally friendly ADME services.
Legal:
- Stringent regulations on drug approval processes require adherence to high testing standards, benefiting the in-vitro ADME market.
- Intellectual property laws and patenting of testing technologies could affect competition and innovation in the market.
Suppliers:
- Providers of raw materials for in-vitro testing, such as chemicals, biological samples, and laboratory equipment.
- Technology providers offering automation, AI, and software solutions for data analysis and testing procedures.
Inputs:
- Biological samples, cell cultures, and chemical compounds required for in-vitro ADME testing.
- Advanced laboratory tools, technology infrastructure, and regulatory compliance documents.
Process:
- Conducting in-vitro ADME testing to evaluate the absorption, distribution, metabolism, and excretion properties of compounds.
- Analyzing results through high-throughput screening, automated systems, and AI-driven data analytics.
Outputs:
- Detailed ADME profiles of compounds for drug developers, including absorption rates, metabolic pathways, and excretion data.
- Reports and recommendations for the optimization of drug candidates in the development pipeline.
Customers:
- Pharmaceutical and biotechnology companies seeking to optimize drug development processes.
- Research institutions and regulatory bodies requiring ADME testing data to assess drug safety and efficacy.
Threat of New Entrants:
- High initial capital investment and specialized expertise required to compete in the in-vitro ADME services market can deter new entrants.
- Established players with strong customer relationships and regulatory compliance experience create barriers to entry for newcomers.
Bargaining Power of Suppliers:
- Limited suppliers for high-quality biological samples and advanced lab technologies may give suppliers significant bargaining power.
- Technological advancements and partnerships with specialized suppliers can mitigate the risk of supplier dominance.
Bargaining Power of Buyers:
- Large pharmaceutical companies have high bargaining power due to their substantial demand for in-vitro ADME services and ability to negotiate lower prices.
- The growing number of service providers offers more options for buyers, potentially reducing their bargaining power over time.
Threat of Substitutes:
- The increasing adoption of in-silico modeling and computational drug discovery methods may serve as substitutes to traditional in-vitro testing.
- However, in-vitro testing remains the preferred method for accurate, real-world validation of drug properties.
Industry Rivalry:
- Intense competition among established players and new entrants, as well as a growing number of service providers, drives up competitive rivalry.
- Companies compete on factors such as technology innovation, regulatory compliance, and customer relationships to differentiate themselves.
Raw Materials:
- Suppliers of biological samples, chemicals, and reagents are crucial in providing the essential materials for in-vitro ADME testing.
- The quality and availability of these raw materials directly impact the reliability and accuracy of the testing process.
Technology Providers:
- Companies offering automation, high-throughput screening, and AI-driven analytics contribute significantly to the efficiency and scalability of ADME testing.
- Advancements in testing technology allow for faster and more precise testing, driving innovation and improving service offerings.
Regulatory Bodies:
- Regulatory requirements set by agencies such as the FDA and EMA guide the standards for testing procedures, influencing service providers’ operations.
- Compliance with stringent regulatory frameworks ensures the credibility and acceptance of in-vitro ADME services in the market.
Research and Development:
- Investment in R&D by pharmaceutical companies and research institutions influences the demand for ADME testing services for new drug candidates.
- Ongoing innovation in ADME testing methodologies improves the overall effectiveness of the services and helps meet the evolving needs of the market.
Service Providers:
- Contract research organizations (CROs) and dedicated service providers conduct in-vitro ADME testing and offer results to pharmaceutical and biotech clients.
- Service providers compete by offering specialized testing services, such as advanced models for absorption and metabolism studies.
Testing and Analysis:
- In-vitro ADME testing involves processes like high-throughput screening, metabolite identification, and bioavailability studies, which are critical to drug development.
- Service providers leverage automation and AI technologies to increase the accuracy, speed, and efficiency of testing and analysis.
Market Demand:
- The demand for in-vitro ADME testing services is driven by the increasing need for drug safety and efficacy evaluation in the pharmaceutical and biotechnology sectors.
- Rising interest in personalized medicine and targeted therapies further fuels the demand for accurate ADME data.
Customer Interaction:
- Pharmaceutical companies rely on ADME testing services to make informed decisions about drug candidates and streamline development processes.
- Research institutions and regulatory bodies also drive demand by requiring in-vitro testing data for regulatory approval and safety assessments.
End-Users:
- Pharmaceutical and biotechnology companies are the primary end-users, utilizing ADME testing data for drug discovery, development, and optimization.
- Academic and research institutions also play a key role in utilizing these services for advancing drug safety research and preclinical studies.
Regulatory Approval:
- In-vitro ADME data is essential for regulatory submissions, ensuring that drugs meet safety and efficacy standards before reaching the market.
- Regulatory agencies, such as the FDA and EMA, rely on accurate ADME testing data to assess drug candidates for approval, influencing the demand for these services.
Market Trends:
- The growing focus on personalized medicine and the increasing complexity of drug development are driving greater reliance on in-vitro ADME testing for precise drug efficacy profiles.
- The rise of biotech and pharmaceutical startups is expanding the market for outsourced ADME testing services, as smaller companies seek cost-effective solutions.
Chapter 1, to describe In - Vitro ADME Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In - Vitro ADME Services, with revenue, gross margin and global market share of In - Vitro ADME Services from 2018 to 2023.
Chapter 3, the In - Vitro ADME Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and In - Vitro ADME Services market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of In - Vitro ADME Services.
Chapter 13, to describe In - Vitro ADME Services research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of In - Vitro ADME Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of In - Vitro ADME Services by Type
1.3.1 Overview: Global In - Vitro ADME Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global In - Vitro ADME Services Consumption Value Market Share by Type in 2022
1.3.3 Small Molecules
1.3.4 Biologics
1.4 Global In - Vitro ADME Services Market by End User
1.4.1 Overview: Global In - Vitro ADME Services Market Size by End User: 2018 Versus 2022 Versus 2029
1.4.2 Biopharmaceutical Companies
1.4.3 Government and Academic Institutes
1.4.4 Others
1.5 Global In - Vitro ADME Services Market Size & Forecast
1.6 Global In - Vitro ADME Services Market Size and Forecast by Region
1.6.1 Global In - Vitro ADME Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global In - Vitro ADME Services Market Size by Region, (2018-2029)
1.6.3 North America In - Vitro ADME Services Market Size and Prospect (2018-2029)
1.6.4 Europe In - Vitro ADME Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific In - Vitro ADME Services Market Size and Prospect (2018-2029)
1.6.6 South America In - Vitro ADME Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa In - Vitro ADME Services Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River In - Vitro ADME Services Product and Solutions
2.1.4 Charles River In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Charles River Recent Developments and Future Plans
2.2 Labcorp
2.2.1 Labcorp Details
2.2.2 Labcorp Major Business
2.2.3 Labcorp In - Vitro ADME Services Product and Solutions
2.2.4 Labcorp In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Labcorp Recent Developments and Future Plans
2.3 Envigo
2.3.1 Envigo Details
2.3.2 Envigo Major Business
2.3.3 Envigo In - Vitro ADME Services Product and Solutions
2.3.4 Envigo In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Envigo Recent Developments and Future Plans
2.4 Curia
2.4.1 Curia Details
2.4.2 Curia Major Business
2.4.3 Curia In - Vitro ADME Services Product and Solutions
2.4.4 Curia In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Curia Recent Developments and Future Plans
2.5 Evotec
2.5.1 Evotec Details
2.5.2 Evotec Major Business
2.5.3 Evotec In - Vitro ADME Services Product and Solutions
2.5.4 Evotec In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Evotec Recent Developments and Future Plans
2.6 Bioduro-Sundia
2.6.1 Bioduro-Sundia Details
2.6.2 Bioduro-Sundia Major Business
2.6.3 Bioduro-Sundia In - Vitro ADME Services Product and Solutions
2.6.4 Bioduro-Sundia In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bioduro-Sundia Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza In - Vitro ADME Services Product and Solutions
2.7.4 Lonza In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lonza Recent Developments and Future Plans
2.8 WuXi AppTec
2.8.1 WuXi AppTec Details
2.8.2 WuXi AppTec Major Business
2.8.3 WuXi AppTec In - Vitro ADME Services Product and Solutions
2.8.4 WuXi AppTec In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 WuXi AppTec Recent Developments and Future Plans
2.9 IQVIA
2.9.1 IQVIA Details
2.9.2 IQVIA Major Business
2.9.3 IQVIA In - Vitro ADME Services Product and Solutions
2.9.4 IQVIA In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 IQVIA Recent Developments and Future Plans
2.10 Tecan Group
2.10.1 Tecan Group Details
2.10.2 Tecan Group Major Business
2.10.3 Tecan Group In - Vitro ADME Services Product and Solutions
2.10.4 Tecan Group In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Tecan Group Recent Developments and Future Plans
2.11 Pharmaron
2.11.1 Pharmaron Details
2.11.2 Pharmaron Major Business
2.11.3 Pharmaron In - Vitro ADME Services Product and Solutions
2.11.4 Pharmaron In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pharmaron Recent Developments and Future Plans
2.12 Shanghai Medicilon
2.12.1 Shanghai Medicilon Details
2.12.2 Shanghai Medicilon Major Business
2.12.3 Shanghai Medicilon In - Vitro ADME Services Product and Solutions
2.12.4 Shanghai Medicilon In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Medicilon Recent Developments and Future Plans
2.13 ChemPartner
2.13.1 ChemPartner Details
2.13.2 ChemPartner Major Business
2.13.3 ChemPartner In - Vitro ADME Services Product and Solutions
2.13.4 ChemPartner In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ChemPartner Recent Developments and Future Plans
2.14 Joinn Laboratories
2.14.1 Joinn Laboratories Details
2.14.2 Joinn Laboratories Major Business
2.14.3 Joinn Laboratories In - Vitro ADME Services Product and Solutions
2.14.4 Joinn Laboratories In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Joinn Laboratories Recent Developments and Future Plans
2.15 RTI International
2.15.1 RTI International Details
2.15.2 RTI International Major Business
2.15.3 RTI International In - Vitro ADME Services Product and Solutions
2.15.4 RTI International In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 RTI International Recent Developments and Future Plans
2.16 Eurofins Scientific
2.16.1 Eurofins Scientific Details
2.16.2 Eurofins Scientific Major Business
2.16.3 Eurofins Scientific In - Vitro ADME Services Product and Solutions
2.16.4 Eurofins Scientific In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Eurofins Scientific Recent Developments and Future Plans
2.17 Aragen Life Sciences
2.17.1 Aragen Life Sciences Details
2.17.2 Aragen Life Sciences Major Business
2.17.3 Aragen Life Sciences In - Vitro ADME Services Product and Solutions
2.17.4 Aragen Life Sciences In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Aragen Life Sciences Recent Developments and Future Plans
2.18 Sai Life Sciences
2.18.1 Sai Life Sciences Details
2.18.2 Sai Life Sciences Major Business
2.18.3 Sai Life Sciences In - Vitro ADME Services Product and Solutions
2.18.4 Sai Life Sciences In - Vitro ADME Services Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Sai Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In - Vitro ADME Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of In - Vitro ADME Services by Company Revenue
3.2.2 Top 3 In - Vitro ADME Services Players Market Share in 2022
3.2.3 Top 6 In - Vitro ADME Services Players Market Share in 2022
3.3 In - Vitro ADME Services Market: Overall Company Footprint Analysis
3.3.1 In - Vitro ADME Services Market: Region Footprint
3.3.2 In - Vitro ADME Services Market: Company Product Type Footprint
3.3.3 In - Vitro ADME Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global In - Vitro ADME Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global In - Vitro ADME Services Market Forecast by Type (2024-2029)
5 Market Size Segment by End User
5.1 Global In - Vitro ADME Services Consumption Value Market Share by End User (2018-2023)
5.2 Global In - Vitro ADME Services Market Forecast by End User (2024-2029)
6 North America
6.1 North America In - Vitro ADME Services Consumption Value by Type (2018-2029)
6.2 North America In - Vitro ADME Services Consumption Value by End User (2018-2029)
6.3 North America In - Vitro ADME Services Market Size by Country
6.3.1 North America In - Vitro ADME Services Consumption Value by Country (2018-2029)
6.3.2 United States In - Vitro ADME Services Market Size and Forecast (2018-2029)
6.3.3 Canada In - Vitro ADME Services Market Size and Forecast (2018-2029)
6.3.4 Mexico In - Vitro ADME Services Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe In - Vitro ADME Services Consumption Value by Type (2018-2029)
7.2 Europe In - Vitro ADME Services Consumption Value by End User (2018-2029)
7.3 Europe In - Vitro ADME Services Market Size by Country
7.3.1 Europe In - Vitro ADME Services Consumption Value by Country (2018-2029)
7.3.2 Germany In - Vitro ADME Services Market Size and Forecast (2018-2029)
7.3.3 France In - Vitro ADME Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom In - Vitro ADME Services Market Size and Forecast (2018-2029)
7.3.5 Russia In - Vitro ADME Services Market Size and Forecast (2018-2029)
7.3.6 Italy In - Vitro ADME Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific In - Vitro ADME Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific In - Vitro ADME Services Consumption Value by End User (2018-2029)
8.3 Asia-Pacific In - Vitro ADME Services Market Size by Region
8.3.1 Asia-Pacific In - Vitro ADME Services Consumption Value by Region (2018-2029)
8.3.2 China In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.3 Japan In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.4 South Korea In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.5 India In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia In - Vitro ADME Services Market Size and Forecast (2018-2029)
8.3.7 Australia In - Vitro ADME Services Market Size and Forecast (2018-2029)
9 South America
9.1 South America In - Vitro ADME Services Consumption Value by Type (2018-2029)
9.2 South America In - Vitro ADME Services Consumption Value by End User (2018-2029)
9.3 South America In - Vitro ADME Services Market Size by Country
9.3.1 South America In - Vitro ADME Services Consumption Value by Country (2018-2029)
9.3.2 Brazil In - Vitro ADME Services Market Size and Forecast (2018-2029)
9.3.3 Argentina In - Vitro ADME Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa In - Vitro ADME Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa In - Vitro ADME Services Consumption Value by End User (2018-2029)
10.3 Middle East & Africa In - Vitro ADME Services Market Size by Country
10.3.1 Middle East & Africa In - Vitro ADME Services Consumption Value by Country (2018-2029)
10.3.2 Turkey In - Vitro ADME Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia In - Vitro ADME Services Market Size and Forecast (2018-2029)
10.3.4 UAE In - Vitro ADME Services Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 In - Vitro ADME Services Market Drivers
11.2 In - Vitro ADME Services Market Restraints
11.3 In - Vitro ADME Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 In - Vitro ADME Services Industry Chain
12.2 In - Vitro ADME Services Upstream Analysis
12.3 In - Vitro ADME Services Midstream Analysis
12.4 In - Vitro ADME Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global In - Vitro ADME Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global In - Vitro ADME Services Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
Table 3. Global In - Vitro ADME Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global In - Vitro ADME Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Charles River Company Information, Head Office, and Major Competitors
Table 6. Charles River Major Business
Table 7. Charles River In - Vitro ADME Services Product and Solutions
Table 8. Charles River In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Charles River Recent Developments and Future Plans
Table 10. Labcorp Company Information, Head Office, and Major Competitors
Table 11. Labcorp Major Business
Table 12. Labcorp In - Vitro ADME Services Product and Solutions
Table 13. Labcorp In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Labcorp Recent Developments and Future Plans
Table 15. Envigo Company Information, Head Office, and Major Competitors
Table 16. Envigo Major Business
Table 17. Envigo In - Vitro ADME Services Product and Solutions
Table 18. Envigo In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Envigo Recent Developments and Future Plans
Table 20. Curia Company Information, Head Office, and Major Competitors
Table 21. Curia Major Business
Table 22. Curia In - Vitro ADME Services Product and Solutions
Table 23. Curia In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Curia Recent Developments and Future Plans
Table 25. Evotec Company Information, Head Office, and Major Competitors
Table 26. Evotec Major Business
Table 27. Evotec In - Vitro ADME Services Product and Solutions
Table 28. Evotec In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Evotec Recent Developments and Future Plans
Table 30. Bioduro-Sundia Company Information, Head Office, and Major Competitors
Table 31. Bioduro-Sundia Major Business
Table 32. Bioduro-Sundia In - Vitro ADME Services Product and Solutions
Table 33. Bioduro-Sundia In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bioduro-Sundia Recent Developments and Future Plans
Table 35. Lonza Company Information, Head Office, and Major Competitors
Table 36. Lonza Major Business
Table 37. Lonza In - Vitro ADME Services Product and Solutions
Table 38. Lonza In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Lonza Recent Developments and Future Plans
Table 40. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 41. WuXi AppTec Major Business
Table 42. WuXi AppTec In - Vitro ADME Services Product and Solutions
Table 43. WuXi AppTec In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. WuXi AppTec Recent Developments and Future Plans
Table 45. IQVIA Company Information, Head Office, and Major Competitors
Table 46. IQVIA Major Business
Table 47. IQVIA In - Vitro ADME Services Product and Solutions
Table 48. IQVIA In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. IQVIA Recent Developments and Future Plans
Table 50. Tecan Group Company Information, Head Office, and Major Competitors
Table 51. Tecan Group Major Business
Table 52. Tecan Group In - Vitro ADME Services Product and Solutions
Table 53. Tecan Group In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Tecan Group Recent Developments and Future Plans
Table 55. Pharmaron Company Information, Head Office, and Major Competitors
Table 56. Pharmaron Major Business
Table 57. Pharmaron In - Vitro ADME Services Product and Solutions
Table 58. Pharmaron In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Pharmaron Recent Developments and Future Plans
Table 60. Shanghai Medicilon Company Information, Head Office, and Major Competitors
Table 61. Shanghai Medicilon Major Business
Table 62. Shanghai Medicilon In - Vitro ADME Services Product and Solutions
Table 63. Shanghai Medicilon In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Shanghai Medicilon Recent Developments and Future Plans
Table 65. ChemPartner Company Information, Head Office, and Major Competitors
Table 66. ChemPartner Major Business
Table 67. ChemPartner In - Vitro ADME Services Product and Solutions
Table 68. ChemPartner In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ChemPartner Recent Developments and Future Plans
Table 70. Joinn Laboratories Company Information, Head Office, and Major Competitors
Table 71. Joinn Laboratories Major Business
Table 72. Joinn Laboratories In - Vitro ADME Services Product and Solutions
Table 73. Joinn Laboratories In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Joinn Laboratories Recent Developments and Future Plans
Table 75. RTI International Company Information, Head Office, and Major Competitors
Table 76. RTI International Major Business
Table 77. RTI International In - Vitro ADME Services Product and Solutions
Table 78. RTI International In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. RTI International Recent Developments and Future Plans
Table 80. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 81. Eurofins Scientific Major Business
Table 82. Eurofins Scientific In - Vitro ADME Services Product and Solutions
Table 83. Eurofins Scientific In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Eurofins Scientific Recent Developments and Future Plans
Table 85. Aragen Life Sciences Company Information, Head Office, and Major Competitors
Table 86. Aragen Life Sciences Major Business
Table 87. Aragen Life Sciences In - Vitro ADME Services Product and Solutions
Table 88. Aragen Life Sciences In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Aragen Life Sciences Recent Developments and Future Plans
Table 90. Sai Life Sciences Company Information, Head Office, and Major Competitors
Table 91. Sai Life Sciences Major Business
Table 92. Sai Life Sciences In - Vitro ADME Services Product and Solutions
Table 93. Sai Life Sciences In - Vitro ADME Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Sai Life Sciences Recent Developments and Future Plans
Table 95. Global In - Vitro ADME Services Revenue (USD Million) by Players (2018-2023)
Table 96. Global In - Vitro ADME Services Revenue Share by Players (2018-2023)
Table 97. Breakdown of In - Vitro ADME Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in In - Vitro ADME Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key In - Vitro ADME Services Players
Table 100. In - Vitro ADME Services Market: Company Product Type Footprint
Table 101. In - Vitro ADME Services Market: Company Product Application Footprint
Table 102. In - Vitro ADME Services New Market Entrants and Barriers to Market Entry
Table 103. In - Vitro ADME Services Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global In - Vitro ADME Services Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global In - Vitro ADME Services Consumption Value Share by Type (2018-2023)
Table 106. Global In - Vitro ADME Services Consumption Value Forecast by Type (2024-2029)
Table 107. Global In - Vitro ADME Services Consumption Value by End User (2018-2023)
Table 108. Global In - Vitro ADME Services Consumption Value Forecast by End User (2024-2029)
Table 109. North America In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 112. North America In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 113. North America In - Vitro ADME Services Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America In - Vitro ADME Services Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 118. Europe In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 119. Europe In - Vitro ADME Services Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe In - Vitro ADME Services Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 124. Asia-Pacific In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 125. Asia-Pacific In - Vitro ADME Services Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific In - Vitro ADME Services Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 130. South America In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 131. South America In - Vitro ADME Services Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America In - Vitro ADME Services Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa In - Vitro ADME Services Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa In - Vitro ADME Services Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa In - Vitro ADME Services Consumption Value by End User (2018-2023) & (USD Million)
Table 136. Middle East & Africa In - Vitro ADME Services Consumption Value by End User (2024-2029) & (USD Million)
Table 137. Middle East & Africa In - Vitro ADME Services Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa In - Vitro ADME Services Consumption Value by Country (2024-2029) & (USD Million)
Table 139. In - Vitro ADME Services Raw Material
Table 140. Key Suppliers of In - Vitro ADME Services Raw Materials
List of Figures
Figure 1. In - Vitro ADME Services Picture
Figure 2. Global In - Vitro ADME Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global In - Vitro ADME Services Consumption Value Market Share by Type in 2022
Figure 4. Small Molecules
Figure 5. Biologics
Figure 6. Global In - Vitro ADME Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. In - Vitro ADME Services Consumption Value Market Share by End User in 2022
Figure 8. Biopharmaceutical Companies Picture
Figure 9. Government and Academic Institutes Picture
Figure 10. Others Picture
Figure 11. Global In - Vitro ADME Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global In - Vitro ADME Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market In - Vitro ADME Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global In - Vitro ADME Services Consumption Value Market Share by Region (2018-2029)
Figure 15. Global In - Vitro ADME Services Consumption Value Market Share by Region in 2022
Figure 16. North America In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 19. South America In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 21. Global In - Vitro ADME Services Revenue Share by Players in 2022
Figure 22. In - Vitro ADME Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players In - Vitro ADME Services Market Share in 2022
Figure 24. Global Top 6 Players In - Vitro ADME Services Market Share in 2022
Figure 25. Global In - Vitro ADME Services Consumption Value Share by Type (2018-2023)
Figure 26. Global In - Vitro ADME Services Market Share Forecast by Type (2024-2029)
Figure 27. Global In - Vitro ADME Services Consumption Value Share by End User (2018-2023)
Figure 28. Global In - Vitro ADME Services Market Share Forecast by End User (2024-2029)
Figure 29. North America In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 30. North America In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 31. North America In - Vitro ADME Services Consumption Value Market Share by Country (2018-2029)
Figure 32. United States In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 37. Europe In - Vitro ADME Services Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 39. France In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 45. Asia-Pacific In - Vitro ADME Services Consumption Value Market Share by Region (2018-2029)
Figure 46. China In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 49. India In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 52. South America In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 53. South America In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 54. South America In - Vitro ADME Services Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa In - Vitro ADME Services Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa In - Vitro ADME Services Consumption Value Market Share by End User (2018-2029)
Figure 59. Middle East and Africa In - Vitro ADME Services Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE In - Vitro ADME Services Consumption Value (2018-2029) & (USD Million)
Figure 63. In - Vitro ADME Services Market Drivers
Figure 64. In - Vitro ADME Services Market Restraints
Figure 65. In - Vitro ADME Services Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of In - Vitro ADME Services in 2022
Figure 68. Manufacturing Process Analysis of In - Vitro ADME Services
Figure 69. In - Vitro ADME Services Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
